Last reviewed · How we verify
88% sucrose po solution
88% sucrose po solution is a Small molecule drug developed by St. Justine's Hospital. It is currently FDA-approved.
An 88% sucrose solution given orally has been studied as a potential treatment for pain in children aged 1 to 3 months. According to ClinicalTrials.gov, this solution has been compared to a placebo in a randomized double-blind trial for its effect on pain during bladder catheterization.
At a glance
| Generic name | 88% sucrose po solution |
|---|---|
| Sponsor | St. Justine's Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Nasopharyngeal Aspiration (PHASE4)
- Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Bladder Catheterization (PHASE4)
- Effect on Pain of Oral Sucrose Versus Placebo in Children 1 to 3 Months Old Needing Venipuncture (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 88% sucrose po solution CI brief — competitive landscape report
- 88% sucrose po solution updates RSS · CI watch RSS
- St. Justine's Hospital portfolio CI
Frequently asked questions about 88% sucrose po solution
What is 88% sucrose po solution?
Who makes 88% sucrose po solution?
What development phase is 88% sucrose po solution in?
Related
- Manufacturer: St. Justine's Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing